News
Myriad Optics Raises CHF 150’000 from Venture Kick
The EPFL spin-off develops new and disruptive bacterial contamination detection tools that can revolutionize food testing. Testing delays lasting hours to days cost companies millions and expose consumers to health risks. Myriad Optics’ technology targets faster detection to prevent costly recalls and protect public safety. In the food, pharma, and medtech sectors, delays in…
Read MoreClee Medical Wins a W.A. De Vigier Award
Clee Medical, a Wyss Center for Bio and Neuroengineering Geneva spinoff, wins a W.A. De Vigier Award worth CHF 120’000 Clee Medical, a Geneva-based medtech startup, is transforming brain surgery with an advanced platform that combines ultra-high-resolution real-time imaging, AI-based navigation, and machine learning. This technology allows surgeons to operate with extreme precision, reducing…
Read MoreOdne, an EPFL and ETHZ spinoff, raises CHF 4,2 Million in Series A
Odne’s story began through a close collaboration between leading researchers at EPFL and ETHZ, who sought to address long-standing clinical challenges in endodontic therapy. With over CHF 4.2 million raised in its Series A1 round — including support from ZEISS Ventures — and several FDA-cleared products now entering the U.S. market, the medtech company is…
Read MoreNew Lab Spaces Available at Biopôle
Biopôle SA is expanding its offering with 18 brand-new private laboratory units, from 30 to 75 m² each, available from October 2025 in the Trypto building. Since its first building was completed in 2008, Biopôle has grown into a renowned hub with 10 buildings housing over 170 companies and academic institutions such as CHUV…
Read MoreSmart Shoes to Help Prevent Diabetic Foot Amputations
Professor Zoltan Pataky from University of Geneva, has received major funding from the Swiss National Science Foundation (SNSF) to conduct clinical testing on smart shoes designed to prevent foot ulcers in people with diabetes — a leading cause of lower limb amputation. Each year, diabetes leads to an estimated 250,000 amputations in Europe, 85%…
Read MoreAzureCell Therapies Secures Innosuisse Grant to Advance Parkinson Disease Treatment
AzureCell Therapies, a University of Geneva spinoff at the forefront of regenerative medicine, has been awarded a CHF 650,000 grant from Innosuisse, Switzerland’s innovation agency, to advance its pioneering cell-replacement therapies for Parkinson’s disease. Rooted in over 20 years of research from the University of Geneva and backed by over CHF 8 million in…
Read MoreLaxiPed Secures Innosuisse Grant to Revolutionise Foot Orthopaedics with Precision Diagnostics
LaxiPed, a Geneva-based life sciences project, has received an Innosuisse grant of CHF 679,000 to support the clinical validation of its innovative diagnostic device for foot orthopaedics. This key milestone will allow the team to take the next step toward improving diagnosis, surgical planning, and patient outcomes for conditions such as hallux valgus (bunion)—a highly…
Read MoreCHUV inaugurates its Bladder Cancer Center
Inaugurated on 1 June 2025, the Bladder Cancer Center is the eleventh interdisciplinary oncology center created at the University Hospital of Vaud (CHUV). It aims to improve the quality and safety of care by offering patients state-of-the-art treatment combining specialized surgery, innovative systemic therapies, and a rehabilitation programme. Every year in Switzerland, bladder…
Read MoreSwitzerland Innovation Parks and Microsoft Collaboration for AI-Powered Solutions
The Switzerland Innovation Parks and Microsoft have announced a collaboration to accelerate the development and deployment of AI-powered solutions across Switzerland. The collaboration aims to empower startups and SMEs by embedding cutting-edge AI capabilities into the country’s leading innovation environments. This initiative will be implemented locally through the six Switzerland Innovation Parks that…
Read MoreAtinary Technologies Gets Funding to Accelerate Antibiotics Discovery with AI
Atinary Technologies, a pioneering Swiss deeptech startup, has announced its participation in a groundbreaking project funded by AIchemy, a UK-based initiative supported by the Engineering and Physical Sciences Research Council. In partnership with the Frei Lab at the University of York, Atinary is set to transform antibiotic discovery by focusing on a promising yet underexplored…
Read More